retatrutide cardiovascular effects Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide: A deep dive Part

The Bottom Line The excitement around GLP-1 weight loss therapies has highlighted just how powerful this hormone is in regulating appetite, blood sugar, and metabolic health

In clinical trials for weight management, tirzepatide produced average weight loss of 20-25% of body weight, roughly double what semaglutide achieves at comparable endpoints

The safety and effectiveness of semaglutide tablets was evaluated in a 26-week clinical study that included 324 patients with moderate renal impairment (eGFR 30 to 59 mL/min/1.73 m2) [see Clinical Studies (14.1)]

We define microdosing as any dose below the lowest commercially available starting dose

Storage period after opening: corresponds to the actual storage period

So a 12.5% deficit at your starting weight becomes a smaller deficit at a lower weight, even if your eating stays exactly the same